查看购物车
  • Traditional Chinese
  • English
  • Japanese
2021-2031 年亚太地区药物警戒和药物安全软体市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1819688

2021-2031 年亚太地区药物警戒和药物安全软体市场报告（范围、细分、动态和竞争分析）

Asia Pacific Pharmacovigilance and Drug Safety Software Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 227 Pages | 订单完成后即时交付

价格

2023 年亚太地区的药物警戒和药物安全软体市场价值约为 4,440 万美元，预计到 2031 年将成长到 6,866 万美元。这一成长代表着 2023 年至 2031 年的年复合成长率(CAGR) 为 5.6%。

这项市场扩张的重要驱动力在于人工智慧 (AI)、机器学习 (ML) 和自然语言处理 (NLP) 等先进技术的融合。这些技术正在彻底改变药物警戒相关的传统资源密集流程，从而实现更明智、更有效率的营运。现代药物警戒软体平台日益配备了先进的分析和人工智慧功能，增强了对安全讯号的识别能力。透过分析大型资料集，这些工具可以发现传统方法可能遗漏的关联性和模式。此外，人工智慧驱动的预测分析可以预测潜在的安全问题，使企业能够采取主动措施。

机器学习模型在预测与药物使用相关的不良事件方面尤其有用。例如，药物警戒计画利用机器学习分析大量资料集，识别可能暗示药物不良反应风险的模式。这些演算法擅长处理非结构化资料，例如社群媒体内容和病患记录，从而有效预测安全隐患。

市场上一些关键参与者正在开发基于人工智慧的自动化监测工具，以促进製药公司的药物开发。值得注意的是，科睿唯安于2021年5月推出了DialogML，这是一个由人工智慧驱动的药物警戒文献监测软体平台。此工具可自动监测药物警戒文献，简化彙总报告产生和安全讯号审查等流程。 2024年1月，PubHive Ltd.推出了一个创新的集中式产品特性彙总（SmPC）管理平台，该平台整合了人工智慧驱动的药物警戒工作流程。该平台专为生命科学、製药公司和临床研究组织（CRO）设计，旨在提高药物警戒团队的合规性和营运效率。

人工智慧系统在即时药物安全监测中的应用日益普遍，该监测涵盖临床试验资料、医学文献综述和患者登记，以识别不良事件 (AE)。这种主动方法提高了药物不良反应 (ADR) 检测的准确性和速度。此外，自然语言处理 (NLP) 技术使人工智慧系统能够从海量文字资料集中提取相关信息，例如药物名称和症状，从而促进快速准确的不良事件报告。此功能可加速识别新的或先前未知的药物安全问题，显着地推进药物警戒工作。

亚太地区药物警戒和药物安全软体市场涵盖多个国家，包括印度、中国、日本、韩国、澳洲以及亚太地区其他地区。该地区的医疗保健和製药业正经历数位化浪潮。例如，印度政府启动了多个项目，例如「阿育曼印度数位化使命」和「CoWIN」应用程序，旨在提高医疗保健的可及性。同样，澳洲也致力于实现医疗保健和製药业的现代化，并于2022年3月宣布了一项重大投资，金额高达7.491万美元（10.72万澳元）。

在製药公司中，人工智慧与药物警戒和药物安全软体的整合正变得越来越普遍，它们利用这些系统来监测、收集、分析和管理药物安全资料。随着亚太地区对药物警戒的需求不断增长，企业明显倾向于采用先进的软体解决方案。这些工具应用于药物开发的各个阶段，包括上市前、上市后监测、临床试验。因此，製药业数位化措施的兴起以及药物警戒软体的日益普及预计将推动亚太地区市场的成长。

市场进一步根据产品、部署方式、企业规模、软体形式、功能和最终用户进行分类。就产品而言，市场分为软体和服务，其中软体部分在2023年将占据更大的份额。就部署而言，云端部分也占据了相当大的市场份额，反映出人们对基于云端的解决方案的偏好。

从企业规模来看，大型企业占据市场主导地位；从软体形态来看，则分为标准软体和客製化解决方案，其中标准软体占据主导地位。从功能来看，市场涵盖讯号与风险管理、不良事件追踪、个案管理、临床安全管理等细分领域，其中讯号与风险管理最为突出。

就最终用户而言，製药和生物技术公司占据最大的份额，而市场也按国家细分，中国在 2023 年的市场份额将领先。

亚太地区药物警戒和药物安全软体市场的主要参与者包括 Veeva Systems Inc.、IQVIA Holdings Inc.、AB Cube SAS、ArisGlobal LLC、甲骨文公司、Max Application、ICON Plc、Cognizant Technology Solutions Corp、埃森哲公司、Syneos Health Inc.、Genpact Ltd.、Laboraizant Technology Solutions 总部、埃森哲公司、Syneos Health Inc.、Genpact Ltd.、Laboraizant Technology Solutions Holdings、A Technologiesal Solutions。这些公司在开发增强药物安全和药物警戒实践的创新解决方案方面处于领先地位。

目录

第一章：简介

第二章：执行摘要

  • 关键见解
  • 市场吸引力

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：
  • 假设和局限性

第四章：亚太地区药物警戒与药品安全软体市场格局

  • 概述
  • 生态系分析
  • 价值链中的供应商列表

第五章：亚太药物警戒与药品安全软体市场－主要市场动态

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来趋势
  • 驱动因素和限制因素的影响：

第六章：亚太药物警戒与药品安全软体市场 - 分析

  • 2021-2031年亚太地区药物警戒与药物安全软体市场收入
  • 亚太药物警戒与药品安全软体市场预测分析

第七章：亚太药物警戒与药品安全软体市场分析 - 按产品

  • 软体
  • 服务

第 8 章：亚太地区药物警戒与药品安全软体市场分析 - 按部署

  • 云
  • 本地

第九章：亚太地区药物警戒与药品安全软体市场分析－依企业规模

  • 大型企业
  • 中小企业

第 10 章：亚太药物警戒与药品安全软体市场分析 - 按形式

  • 标准
  • 客製化

第 11 章：亚太地区药物警戒与药品安全软体市场分析 - 按功能

  • 讯号和风险管理
  • 问题跟踪和不良事件跟踪
  • 案件管理
  • 临床安全管理与临床试验安全
  • 品质与合规
  • 医学写作
  • 审计支援和培训合规性
  • 医疗保健分析
  • 其他的

第 12 章：亚太药物警戒与药品安全软体市场分析 - 按最终用户

  • 製药和生物技术公司
  • 合约研究组织
  • 业务流程外包（BPO）公司
  • 其他的

第 13 章：亚太药物警戒与药品安全软体市场 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区

第 14 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第 15 章：产业格局

  • 概述
  • 市场倡议
  • 伙伴关係与合作

第 16 章：公司简介

  • ArisGlobal LLC
  • Max Application
  • Oracle Corp
  • Veeva Systems Inc
  • IQVIA Holdings Inc
  • ICON Plc
  • Cognizant Technology Solutions Corp
  • Accenture Plc
  • Syneos Health Inc
  • Genpact Ltd.
  • AB Cube S.A.S.
  • Laboratory Corp of America Holdings
  • Parexel International Corp
  • Qinecsa Solutions
  • Clinevo Technologies

第 17 章：附录

Product Code: TIPRE00022770

The pharmacovigilance and drug safety software market in the Asia Pacific region was valued at approximately US$ 44.40 million in 2023, with projections indicating it will grow to US$ 68.66 million by 2031. This growth represents a compound annual growth rate (CAGR) of 5.6% from 2023 to 2031.

A significant driver of this market expansion is the integration of advanced technologies such as artificial intelligence (AI), machine learning (ML), and natural language processing (NLP). These technologies are revolutionizing the traditionally resource-intensive processes associated with pharmacovigilance, leading to more informed and efficient operations. Modern pharmacovigilance software platforms are increasingly equipped with sophisticated analytics and AI capabilities that enhance the identification of safety signals. By analyzing large datasets, these tools can uncover correlations and patterns that might be missed by conventional methods. Furthermore, AI-driven predictive analytics can anticipate potential safety issues, enabling companies to implement proactive measures.

Machine learning models are particularly useful in predicting adverse events related to drug use. For example, pharmacovigilance initiatives utilize ML to analyze extensive datasets, identifying patterns that may suggest risks of adverse drug reactions. These algorithms excel at processing unstructured data, such as social media content and patient records, to forecast safety concerns effectively.

Several key players in the market are developing automated AI-based monitoring tools to facilitate drug development for pharmaceutical companies. Notably, in May 2021, Clarivate introduced DialogML, an AI-driven pharmacovigilance literature monitoring software platform. This tool automates the monitoring of pharmacovigilance literature, streamlining processes such as aggregate report generation and safety signal reviews. In January 2024, PubHive Ltd. launched an innovative centralized summary of product characteristics (SmPC) management platform that incorporates AI-powered pharmacovigilance workflows. This platform is designed for life sciences, pharmaceutical companies, and clinical research organizations (CROs), enhancing compliance and operational efficiency for pharmacovigilance teams.

The use of AI systems is increasingly prevalent in real-time drug safety monitoring, which encompasses clinical trial data, medical literature reviews, and patient registries to identify adverse events (AEs). This proactive approach improves the accuracy and speed of adverse drug reaction (ADR) detection. Additionally, NLP technologies enable AI systems to extract pertinent information, such as drug names and symptoms, from extensive textual datasets, facilitating rapid and accurate adverse event reporting. This capability accelerates the identification of new or previously unknown drug safety issues, significantly advancing pharmacovigilance efforts.

The Asia Pacific pharmacovigilance and drug safety software market is segmented into various countries, including India, China, Japan, South Korea, Australia, and the rest of the Asia Pacific region. The region is experiencing a surge in digitization within its healthcare and pharmaceutical sectors. For instance, the Indian government has initiated several programs, such as the Ayushman Bharat Digital Mission and the CoWIN App, aimed at enhancing healthcare accessibility. Similarly, Australia has committed to modernizing its healthcare and pharmaceutical sectors, with a notable investment of US$ 74.91 thousand (AU$ 107.2 thousand) announced in March 2022.

The integration of AI in pharmacovigilance and drug safety software is becoming increasingly common among pharmaceutical companies, which utilize these systems to monitor, collect, analyze, and manage drug safety data. As the demand for pharmacovigilance grows across the region, there is a marked shift towards adopting advanced software solutions. These tools are employed throughout various stages of drug development, including pre-marketing and post-marketing surveillance, as well as during clinical trials. Consequently, the rise in digitalization initiatives within the pharmaceutical sector and the increasing adoption of pharmacovigilance software are expected to drive market growth in the Asia Pacific region.

The market is further categorized based on offerings, deployment methods, enterprise size, software form, functionality, and end users. In terms of offerings, the market is divided into software and services, with the software segment holding a larger share in 2023. Regarding deployment, the cloud segment has also captured a significant market share, reflecting a preference for cloud-based solutions.

When considering enterprise size, large enterprises dominate the market, while the software form is categorized into standard and customized solutions, with standard software leading in market share. Functionality-wise, the market includes segments such as signal and risk management, adverse event tracking, case management, and clinical safety management, with signal and risk management being the most prominent segment.

In terms of end users, pharmaceutical and biotechnology companies represent the largest segment, while the market is also segmented by country, with China leading in market share in 2023.

Key players in the Asia Pacific pharmacovigilance and drug safety software market include Veeva Systems Inc., IQVIA Holdings Inc., AB Cube S.A.S., ArisGlobal LLC, Oracle Corp, Max Application, ICON Plc, Cognizant Technology Solutions Corp, Accenture Plc, Syneos Health Inc., Genpact Ltd., Laboratory Corp of America Holdings, Parexel International Corp, Qinecsa Solutions, and Clinevo Technologies. These companies are at the forefront of developing innovative solutions that enhance drug safety and pharmacovigilance practices.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:
  • 3.3 Assumptions and Limitations

4. Asia Pacific Pharmacovigilance and Drug Safety Software Market Landscape

  • 4.1 Overview
  • 4.2 Ecosystem Analysis
  • 4.3 Lit of Vendors in the Value Chain

5. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics

  • 5.1 Market Drivers
  • 5.2 Market Restraints
  • 5.3 Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact of Drivers and Restraints:

6. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Analysis

  • 6.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast Analysis

7. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Offering

  • 7.1 Software
    • 7.1.1 Overview
    • 7.1.2 Software: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 7.2 Services
    • 7.2.1 Overview
    • 7.2.2 Services: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Deployment

  • 8.1 Cloud
    • 8.1.1 Overview
    • 8.1.2 Cloud: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 8.2 On Premises
    • 8.2.1 Overview
    • 8.2.2 On Premises: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Enterprise Size

  • 9.1 Large Enterprises
    • 9.1.1 Overview
    • 9.1.2 Large Enterprises: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 9.2 SMEs
    • 9.2.1 Overview
    • 9.2.2 SMEs: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

10. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Form

  • 10.1 Standard
    • 10.1.1 Overview
    • 10.1.2 Standard: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 10.2 Customized
    • 10.2.1 Overview
    • 10.2.2 Customized: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

11. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by Functionality

  • 11.1 Signal and Risk Management
    • 11.1.1 Overview
    • 11.1.2 Signal and Risk Management: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.2 Issue Tracking and Adverse Event Tracking
    • 11.2.1 Overview
    • 11.2.2 Issue Tracking and Adverse Event Tracking: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.3 Case Management
    • 11.3.1 Overview
    • 11.3.2 Case Management: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.4 Clinical Safety Management and Clinical Trial Safety
    • 11.4.1 Overview
    • 11.4.2 Clinical Safety Management and Clinical Trial Safety: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.5 Quality and Compliance
    • 11.5.1 Overview
    • 11.5.2 Quality and Compliance: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.6 Medical Writing
    • 11.6.1 Overview
    • 11.6.2 Medical Writing: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.7 Audit Support and Training Compliance
    • 11.7.1 Overview
    • 11.7.2 Audit Support and Training Compliance: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.8 Healthcare Analytics
    • 11.8.1 Overview
    • 11.8.2 Healthcare Analytics: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 11.9 Others
    • 11.9.1 Overview
    • 11.9.2 Others: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

12. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis - by End User

  • 12.1 Pharmaceutical and Biotechnology Companies
    • 12.1.1 Overview
    • 12.1.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.2 Contract Research Organizations
    • 12.2.1 Overview
    • 12.2.2 Contract Research Organizations: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.3 Business Process Outsourcing (BPO) Firms
    • 12.3.1 Overview
    • 12.3.2 Business Process Outsourcing (BPO) Firms: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • 12.4 Others
    • 12.4.1 Overview
    • 12.4.2 Others: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

13. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Country Analysis

  • 13.1 Asia Pacific
    • 13.1.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.1.1.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast Analysis - by Country
      • 13.1.1.2 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.2.1 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.2.2 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.2.3 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.2.4 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.2.5 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.2.6 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.3 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.3.1 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.3.2 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.3.3 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.3.4 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.3.5 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.3.6 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.4 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.4.1 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.4.2 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.4.3 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.4.4 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.4.5 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.4.6 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.5 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.5.1 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.5.2 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.5.3 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.5.4 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.5.5 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.5.6 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.6 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.6.1 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.6.2 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.6.3 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.6.4 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.6.5 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.6.6 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User
      • 13.1.1.7 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
        • 13.1.1.7.1 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Offering
        • 13.1.1.7.2 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Deployment
        • 13.1.1.7.3 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Enterprise Size
        • 13.1.1.7.4 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Form
        • 13.1.1.7.5 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by Functionality
        • 13.1.1.7.6 Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market Share - by End User

14. Competitive Landscape

  • 14.1 Heat Map Analysis by Key Players
  • 14.2 Company Positioning and Concentration

15. Industry Landscape

  • 15.1 Overview
  • 15.2 Market Initiative
  • 15.3 Partnerships and Collaborations

16. Company Profiles

  • 16.1 ArisGlobal LLC
    • 16.1.1 Key Facts
    • 16.1.2 Business Description
    • 16.1.3 Products and Services
    • 16.1.4 Financial Overview
    • 16.1.5 SWOT Analysis
    • 16.1.6 Key Developments
  • 16.2 Max Application
    • 16.2.1 Key Facts
    • 16.2.2 Business Description
    • 16.2.3 Products and Services
    • 16.2.4 Financial Overview
    • 16.2.5 SWOT Analysis
    • 16.2.6 Key Developments
  • 16.3 Oracle Corp
    • 16.3.1 Key Facts
    • 16.3.2 Business Description
    • 16.3.3 Products and Services
    • 16.3.4 Financial Overview
    • 16.3.5 SWOT Analysis
    • 16.3.6 Key Developments
  • 16.4 Veeva Systems Inc
    • 16.4.1 Key Facts
    • 16.4.2 Business Description
    • 16.4.3 Products and Services
    • 16.4.4 Financial Overview
    • 16.4.5 SWOT Analysis
    • 16.4.6 Key Developments
  • 16.5 IQVIA Holdings Inc
    • 16.5.1 Key Facts
    • 16.5.2 Business Description
    • 16.5.3 Products and Services
    • 16.5.4 Financial Overview
    • 16.5.5 SWOT Analysis
    • 16.5.6 Key Developments
  • 16.6 ICON Plc
    • 16.6.1 Key Facts
    • 16.6.2 Business Description
    • 16.6.3 Products and Services
    • 16.6.4 Financial Overview
    • 16.6.5 SWOT Analysis
    • 16.6.6 Key Developments
  • 16.7 Cognizant Technology Solutions Corp
    • 16.7.1 Key Facts
    • 16.7.2 Business Description
    • 16.7.3 Products and Services
    • 16.7.4 Financial Overview
    • 16.7.5 SWOT Analysis
    • 16.7.6 Key Developments
  • 16.8 Accenture Plc
    • 16.8.1 Key Facts
    • 16.8.2 Business Description
    • 16.8.3 Products and Services
    • 16.8.4 Financial Overview
    • 16.8.5 SWOT Analysis
    • 16.8.6 Key Developments
  • 16.9 Syneos Health Inc
    • 16.9.1 Key Facts
    • 16.9.2 Business Description
    • 16.9.3 Products and Services
    • 16.9.4 Financial Overview
    • 16.9.5 SWOT Analysis
    • 16.9.6 Key Developments
  • 16.10 Genpact Ltd.
    • 16.10.1 Key Facts
    • 16.10.2 Business Description
    • 16.10.3 Products and Services
    • 16.10.4 Financial Overview
    • 16.10.5 SWOT Analysis
    • 16.10.6 Key Developments
  • 16.11 AB Cube S.A.S.
    • 16.11.1 Key Facts
    • 16.11.2 Business Description
    • 16.11.3 Products and Services
    • 16.11.4 Financial Overview
    • 16.11.5 SWOT Analysis
    • 16.11.6 Key Developments
  • 16.12 Laboratory Corp of America Holdings
    • 16.12.1 Key Facts
    • 16.12.2 Business Description
    • 16.12.3 Products and Services
    • 16.12.4 Financial Overview
    • 16.12.5 SWOT Analysis
    • 16.12.6 Key Developments
  • 16.13 Parexel International Corp
    • 16.13.1 Key Facts
    • 16.13.2 Business Description
    • 16.13.3 Products and Services
    • 16.13.4 Financial Overview
    • 16.13.5 SWOT Analysis
    • 16.13.6 Key Developments
  • 16.14 Qinecsa Solutions
    • 16.14.1 Key Facts
    • 16.14.2 Business Description
    • 16.14.3 Products and Services
    • 16.14.4 Financial Overview
    • 16.14.5 SWOT Analysis
    • 16.14.6 Key Developments
  • 16.15 Clinevo Technologies
    • 16.15.1 Key Facts
    • 16.15.2 Business Description
    • 16.15.3 Products and Services
    • 16.15.4 Financial Overview
    • 16.15.5 SWOT Analysis
    • 16.15.6 Key Developments

17. Appendix

  • 17.1 About Us
  • 17.2 List of Abbreviations

List Of Tables

  • Table 1. Asia Pacific Pharmacovigilance and Drug Safety Software Market Segmentation
  • Table 2. List of Vendors
  • Table 3. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Table 4. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Offering
  • Table 5. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Deployment
  • Table 6. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Enterprise Size
  • Table 7. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Form
  • Table 8. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Functionality
  • Table 9. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by End User
  • Table 10. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand) - by Country
  • Table 11. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 12. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 13. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 14. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 15. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 16. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 17. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 18. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 19. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 20. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 21. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 22. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 23. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 24. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 25. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 26. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 27. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 28. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 29. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 30. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 31. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 32. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 33. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 34. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 35. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 36. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 37. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 38. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 39. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 40. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 41. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Offering
  • Table 42. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Deployment
  • Table 43. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Enterprise Size
  • Table 44. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Form
  • Table 45. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by Functionality
  • Table 46. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021 - 2031 (US$ Thousand) - by End User
  • Table 47. List of Abbreviations

List Of Figures

  • Figure 1. Asia Pacific Pharmacovigilance and Drug Safety Software Market Segmentation - Country
  • Figure 2. Asia Pacific Pharmacovigilance and Drug Safety Software Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Offering (2023 and 2031)
  • Figure 6. Software: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 7. Services: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 8. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Deployment (2023 and 2031)
  • Figure 9. Cloud: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 10. On Premises: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 11. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Enterprise Size (2023 and 2031)
  • Figure 12. Large Enterprises: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 13. SMEs: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 14. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Form (2023 and 2031)
  • Figure 15. Standard: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 16. Customized: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 17. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by Functionality (2023 and 2031)
  • Figure 18. Signal and Risk Management: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 19. Issue Tracking and Adverse Event Tracking: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 20. Case Management: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 21. Clinical Safety Management and Clinical Trial Safety: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 22. Quality and Compliance: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 23. Medical Writing: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 24. Audit Support and Training Compliance: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 25. Healthcare Analytics: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 26. Others: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 27. Asia Pacific Pharmacovigilance and Drug Safety Software Market Share (%) - by End User (2023 and 2031)
  • Figure 28. Pharmaceutical and Biotechnology Companies: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 29. Contract Research Organizations: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 30. Business Process Outsourcing (BPO) Firms: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 31. Others: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
  • Figure 32. Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 33. China: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 34. Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 35. India: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 36. South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 37. Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 38. Rest of APAC: Asia Pacific Pharmacovigilance and Drug Safety Software Market - Revenue and Forecast, 2021- 2031 (US$ Thousand)
  • Figure 39. Heat Map Analysis by Key Players
  • Figure 40. Company Positioning and Concentration